Lynk Pharmaceuticals Achieves Breakthrough Results in Phase III Trial of Zemprocitinib for Atopic Dermatitis #China #Shanghai #Atopic_Dermatitis #Lynk_Pharmaceuticals #Zemprocitinib
1
0
0
0
Lynk Pharmaceuticals Achieves Breakthrough Results in Phase III Trial of Zemprocitinib for Atopic Dermatitis #China #Shanghai #Atopic_Dermatitis #Lynk_Pharmaceuticals #Zemprocitinib
Lynk Pharmaceuticals Reports Encouraging Phase III Results for Zemprocitinib in Rheumatoid Arthritis Treatment #China #Hangzhou #rheumatoid_arthritis #Lynk_Pharmaceuticals #Zemprocitinib